Donald K Yang, MD | |
3355 Riverbend Dr, Suite 500, Springfield, OR 97477-8800 | |
(541) 868-9500 | |
(541) 685-5920 |
Full Name | Donald K Yang |
---|---|
Gender | Male |
Speciality | Gastroenterology |
Experience | 26 Years |
Location | 3355 Riverbend Dr, Springfield, Oregon |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023037306 | NPI | - | NPPES |
275113 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | MD24898 (Oregon) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Sacred Heart Medical Center - Riverbend | Springfield, OR | Hospital |
Mercy Medical Center | Roseburg, OR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Eugene Gastroenterology Consultants Pc | 9830185875 | 14 |
News Archive
Pharmaceutical company Pharmaxis today announced that it has enrolled the first subject into its second pivotal Phase 3 clinical trial evaluating Bronchitol in cystic fibrosis sufferers.
GE Healthcare, a unit of General Electric Company, today announced that DaTSCAN (ioflupane I 123 injection), a radiopharmaceutical agent intended for use with single photon emission computed tomography (SPECT) imaging of the brain, has been recommended in updated European Federation of the Neurological Societies (EFNS) guidelines for the diagnosis and management of Alzheimer's disease (AD). The guidelines appear in the October issue of the European Journal of Neurology.
Huntsman Cancer Institute (HCI) at the University of Utah (U of U) today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and Population Equity (HOPE), a new research and clinical space dedicated to preventing cancer and improving health among underserved populations and improving outcomes in cancer patients.
A study in the Philadelphia area found that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants evolve to become more contagious and resistant to COVID-19 vaccines. In addition, depending on the sublineage, SARS-CoV-2 variants such as the Delta variant led to a three-fold increased risk for vaccine breakthrough cases.
Transgenomic, Inc. today announced that it has entered into a Convertible Promissory Note Purchase Agreement in the aggregate amount of $3.0 million with entities associated with Third Security, LLC, a leading life sciences investment firm.
› Verified 6 days ago
Entity Name | Eugene Gastroenterology Consultants Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457374480 PECOS PAC ID: 9830185875 Enrollment ID: O20040423000749 |
News Archive
Pharmaceutical company Pharmaxis today announced that it has enrolled the first subject into its second pivotal Phase 3 clinical trial evaluating Bronchitol in cystic fibrosis sufferers.
GE Healthcare, a unit of General Electric Company, today announced that DaTSCAN (ioflupane I 123 injection), a radiopharmaceutical agent intended for use with single photon emission computed tomography (SPECT) imaging of the brain, has been recommended in updated European Federation of the Neurological Societies (EFNS) guidelines for the diagnosis and management of Alzheimer's disease (AD). The guidelines appear in the October issue of the European Journal of Neurology.
Huntsman Cancer Institute (HCI) at the University of Utah (U of U) today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and Population Equity (HOPE), a new research and clinical space dedicated to preventing cancer and improving health among underserved populations and improving outcomes in cancer patients.
A study in the Philadelphia area found that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants evolve to become more contagious and resistant to COVID-19 vaccines. In addition, depending on the sublineage, SARS-CoV-2 variants such as the Delta variant led to a three-fold increased risk for vaccine breakthrough cases.
Transgenomic, Inc. today announced that it has entered into a Convertible Promissory Note Purchase Agreement in the aggregate amount of $3.0 million with entities associated with Third Security, LLC, a leading life sciences investment firm.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Donald K Yang, MD 3355 Riverbend Dr, Suite 500, Springfield, OR 97477-8800 Ph: (541) 868-9500 | Donald K Yang, MD 3355 Riverbend Dr, Suite 500, Springfield, OR 97477-8800 Ph: (541) 868-9500 |
News Archive
Pharmaceutical company Pharmaxis today announced that it has enrolled the first subject into its second pivotal Phase 3 clinical trial evaluating Bronchitol in cystic fibrosis sufferers.
GE Healthcare, a unit of General Electric Company, today announced that DaTSCAN (ioflupane I 123 injection), a radiopharmaceutical agent intended for use with single photon emission computed tomography (SPECT) imaging of the brain, has been recommended in updated European Federation of the Neurological Societies (EFNS) guidelines for the diagnosis and management of Alzheimer's disease (AD). The guidelines appear in the October issue of the European Journal of Neurology.
Huntsman Cancer Institute (HCI) at the University of Utah (U of U) today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and Population Equity (HOPE), a new research and clinical space dedicated to preventing cancer and improving health among underserved populations and improving outcomes in cancer patients.
A study in the Philadelphia area found that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants evolve to become more contagious and resistant to COVID-19 vaccines. In addition, depending on the sublineage, SARS-CoV-2 variants such as the Delta variant led to a three-fold increased risk for vaccine breakthrough cases.
Transgenomic, Inc. today announced that it has entered into a Convertible Promissory Note Purchase Agreement in the aggregate amount of $3.0 million with entities associated with Third Security, LLC, a leading life sciences investment firm.
› Verified 6 days ago
Yiyakchu Jung Thapa, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: Peacehealth Hospital Medicine, 3377 Riverbend Drive, Springfield, OR 97477 Phone: 541-222-6389 Fax: 541-222-6385 | |
Dr. Luis Eduardo Leyton-gonzalez, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: Peacehealth Hospital Medicine, 3377 Riverbend Drive, Springfield, OR 97477 Phone: 541-222-6389 Fax: 541-222-6385 | |
Dr. Peter A Kovach, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3377 Riverbend Dr, Springfield, OR 97477 Phone: 541-683-5001 | |
Satyam Lakshmanbhai Patel, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3377 Riverbend Dr, Springfield, OR 97477 Phone: 541-222-6389 Fax: 541-222-6385 | |
Priya Joseph Carden, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2073 Olympic Street, Springfield, OR 97477 Phone: 541-682-3550 Fax: 541-682-6703 | |
Jaswinder Kaur Singh, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: Peacehealth Hospital Medicine, 3377 Riverbend Drive, Springfield, OR 97477 Phone: 541-222-6389 Fax: 541-222-6385 |